Notice of Report on Completion of Merger
2023.05.11
Notice of Report on Completion of Merger
Voronoi Inc. has completed all procedures required for the merger as prescribed by the Korean Commercial Act in absorbing and merging with Voronoi Bio Inc. Accordingly, the Company's Board of Directors has resolved, pursuant to Article 526, Paragraphs 1 and 3 of the Korean Commercial Act, to substitute this public notice for the general meeting of shareholders for the merger report, and hereby reports the completion of the merger to each shareholder through this notice as follows.
- Details -
1. Details of the Merger
(1) Parties to the Merger
- Surviving company: Voronoi Inc.
- Dissolving company: Voronoi Bio Inc.
(2) Method of Merger
By way of a small-scale merger pursuant to Article 527-3 of the Korean Commercial Act,
Voronoi Inc. absorbs and merges with Voronoi Bio Inc.
(3) Merger Ratio: Voronoi Inc. : Voronoi Bio Inc. = 1 : 0 (merger without capital increase)
2. Progress of the Merger
(1) Date of Board resolution on the merger: March 8, 2023
(2) Date of execution of the merger agreement: March 9, 2023
(3) Period for notice of dissent by shareholders opposing the small-scale merger: March 23, 2023 ~ April 6, 2023
(4) Date of Board resolution approving the merger in lieu of the general meeting of shareholders: April 7, 2023
(5) Creditor objection period: April 10, 2023 ~ May 10, 2023
(6) Merger date: May 11, 2023
(7) Date of Board resolution in lieu of the general meeting for the report on completion of the merger: May 11, 2023
3. Matters Concerning Creditor Protection
The creditor protection procedures under Article 527-5 of the Korean Commercial Act have been completed.
May 11, 2023
Voronoi Inc.
18F, Bldg. S, IT Center, 32 Songdogwahak-ro, Yeonsu-gu, Incheon, Republic of Korea
CEOs Hyuntae Kim and Daekwon Kim
Voronoi Inc. has completed all procedures required for the merger as prescribed by the Korean Commercial Act in absorbing and merging with Voronoi Bio Inc. Accordingly, the Company's Board of Directors has resolved, pursuant to Article 526, Paragraphs 1 and 3 of the Korean Commercial Act, to substitute this public notice for the general meeting of shareholders for the merger report, and hereby reports the completion of the merger to each shareholder through this notice as follows.
- Details -
1. Details of the Merger
(1) Parties to the Merger
- Surviving company: Voronoi Inc.
- Dissolving company: Voronoi Bio Inc.
(2) Method of Merger
By way of a small-scale merger pursuant to Article 527-3 of the Korean Commercial Act,
Voronoi Inc. absorbs and merges with Voronoi Bio Inc.
(3) Merger Ratio: Voronoi Inc. : Voronoi Bio Inc. = 1 : 0 (merger without capital increase)
2. Progress of the Merger
(1) Date of Board resolution on the merger: March 8, 2023
(2) Date of execution of the merger agreement: March 9, 2023
(3) Period for notice of dissent by shareholders opposing the small-scale merger: March 23, 2023 ~ April 6, 2023
(4) Date of Board resolution approving the merger in lieu of the general meeting of shareholders: April 7, 2023
(5) Creditor objection period: April 10, 2023 ~ May 10, 2023
(6) Merger date: May 11, 2023
(7) Date of Board resolution in lieu of the general meeting for the report on completion of the merger: May 11, 2023
3. Matters Concerning Creditor Protection
The creditor protection procedures under Article 527-5 of the Korean Commercial Act have been completed.
May 11, 2023
Voronoi Inc.
18F, Bldg. S, IT Center, 32 Songdogwahak-ro, Yeonsu-gu, Incheon, Republic of Korea
CEOs Hyuntae Kim and Daekwon Kim